TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16949180

Group type: EXPERIMENTAL
Intervention: Oral glutamine supplements (30 g/day) for 15 days, initiated at least 3 days before chemotherapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Oral glutamine supplements (OGS)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Chemotherapy group
Number of subjects: 51
Study: 16338265

Group type: EXPERIMENTAL
Intervention: Urodilatin 15 ng/(kg.min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Urodilatin 30 ng/(kg.min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11939925

Group type: EXPERIMENTAL
Intervention: i.v. diclofenac 75 mg followed by oral diclofenac 150 mg/day for 3 days
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: ketoprofen 100 mg followed by oral ketoprofen 300 mg/day for 3 days
Number of subjects: 64

Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 64
Study: 9403746

Group type: EXPERIMENTAL
Intervention: Femoral vein catheterization
Number of subjects: 61

Group type: COMPARATOR
Intervention: Superior vena cava catheterization
Number of subjects: 61
Study: 8495452

Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3305795

Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (5‐FU) combined with Adriamycin (FA)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: FA plus methyl‐CCNU (MeFA)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 189
Study: 28345160

Group type: EXPERIMENTAL
Intervention: 3 g l-carnitine + carbohydrate (CARN)
Number of subjects: 21

Group type: COMPARATOR
Intervention: 80 g carbohydrate (CON)
Number of subjects: 21

Group type: COMPARATOR
Intervention: CARN and CON
Number of subjects: 21
Study: 27256768

Group type: EXPERIMENTAL
Intervention: Preoperative bowel preparation with enema
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Preoperative bowel preparation with suppository
Number of subjects: 45

Group type: COMPARATOR
Intervention: No bowel preparation
Number of subjects: 45
Study: 25577862

Group type: EXPERIMENTAL
Intervention: Music (Wolfgang Amadeus Mozart 'Sonata K. 448')
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard procedure
Number of subjects: 35
Study: 22626878

Group type: COMPARATOR
Intervention: Routine fluid administration (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Restricted fluid administration (Group B)
Number of subjects: 40
Study: 20889234

Group type: EXPERIMENTAL
Intervention: Topical hypericin with visible light irradiation (8 to 20 J/cm²), applied twice weekly for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo vehicle
Number of subjects: 0
Study: 18540715

Group type: EXPERIMENTAL
Intervention: Personalized normative feedback birthday card intervention
Number of subjects: 281

Group type: COMPARATOR
Intervention: No birthday card (Control)
Number of subjects: 281
Study: 15840623

Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 103

Group type: COMPARATOR
Intervention: Prehospital fibrinolysis (rt-PA)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Rescue angioplasty
Number of subjects: 103
Study: 12494299

Group type: EXPERIMENTAL
Intervention: Yoghurt (450 g for 4 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Partially skimmed milk (450 g for 4 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nothing (control group)
Number of subjects: 20
Study: 10075361

Group type: EXPERIMENTAL
Intervention: No drains (test group)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Drains (control group)
Number of subjects: 119
Study: 7731155

Group type: EXPERIMENTAL
Intervention: Ionic contrast agent (meglumine/sodium diatrizoate)
Number of subjects: 1196

Group type: COMPARATOR
Intervention: Nonionic contrast agent (iohexol)
Number of subjects: 1196

Group type: EXPERIMENTAL
Intervention: Ionic contrast agent (meglumine/sodium diatrizoate) with RI
Number of subjects: 1196

Group type: COMPARATOR
Intervention: Nonionic contrast agent (iohexol) with RI
Number of subjects: 1196

Group type: EXPERIMENTAL
Intervention: Both contrast agents
Number of subjects: 1196
Study: 1873746

Group type: EXPERIMENTAL
Intervention: Helium-neon laser (632.8 nm at 10 mW) applied for three minutes immediately following surgery
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control side (similar technique without activation of the laser beam)
Number of subjects: 15
Study: 6626426

Group type: COMPARATOR
Intervention: 10 mg pinacidil (single oral dose)
Number of subjects: 6

Group type: COMPARATOR
Intervention: 20 mg pinacidil (mean dose, twice daily for 3‐7 weeks)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Pinacidil (chronic treatment)
Number of subjects: 6
Study: 30179656

Group type: EXPERIMENTAL
Intervention: Piperacillin–tazobactam 4 g/0.5 g at the time of intubation and 12 h later
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Piperacillin–tazobactam
Number of subjects: 84
Study: 29769663

Group type: EXPERIMENTAL
Intervention: Oxytocin administration
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 26181769

Group type: EXPERIMENTAL
Intervention: Screening group (measuring thyroid function and thyroid antibody in early pregnancy)
Number of subjects: 1671

Group type: EXPERIMENTAL
Intervention: Thyroid hormone replacement therapy (for 105 SCH and 4 hypothyroid women in screening group)
Number of subjects: 1671

Group type: EXPERIMENTAL
Intervention: Regular follow‐up visits (for women in screening group who did not take medicine)
Number of subjects: 1671

Group type: COMPARATOR
Intervention: Control group (serum stored and measured shortly after delivery)
Number of subjects: 1671
Study: 25151903

Group type: EXPERIMENTAL
Intervention: Walking exercise from 34 weeks of gestational age to delivery
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group (no structured walking exercise)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Walking exercise
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 239
Study: 21947137

Group type: EXPERIMENTAL
Intervention: Risedronate 35 mg delayed-release (DR) weekly (either before or after breakfast)
Number of subjects: 922

Group type: COMPARATOR
Intervention: Risedronate 5 mg immediate-release (IR) daily
Number of subjects: 922
Study: 19942104

Group type: EXPERIMENTAL
Intervention: Autologous blood therapy (ABT) - gluteal intramuscular reinjection of venous blood three times a week
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo - sterile sodium chloride solution
Number of subjects: 139
Study: 17453747

Group type: EXPERIMENTAL
Intervention: Benazepril plus hydrochlorothiazide
Number of subjects: 11454

Group type: EXPERIMENTAL
Intervention: Amlodipine plus benazepril
Number of subjects: 11454
Study: 15951245

Group type: EXPERIMENTAL
Intervention: MEMA kwa Vijana intervention (teacher-led, peer-assisted sexual health education, training of health workers, peer condom promotion, community activities)
Number of subjects: 9645

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 9645
Study: 12174785

Group type: EXPERIMENTAL
Intervention: 15 mg/kg quinine twice a day for 3 days (group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 mg/kg quinine twice a day for 3 days followed by a total dose of 25 mg chloroquine base over 3 days (group 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 mg/kg chloroquine base given in 2 daily doses for 3 days (group 3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: sulfadoxine-pyrimethamine (group 4)
Number of subjects: 0
Study: 9844152

Group type: EXPERIMENTAL
Intervention: Bicarbonate-buffered peritoneal dialysis solution (34 mmol/liter)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Lactate-buffered peritoneal dialysis solution (35 mmol/liter)
Number of subjects: 123
Study: 7813599

Group type: EXPERIMENTAL
Intervention: Roxindole 1 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 2673441

Group type: EXPERIMENTAL
Intervention: Calcium carbimide (CC)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 851140

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 10 per cent ethanol
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of ritodrine for 12 hours followed by oral ritodrine
Number of subjects: 135
Study: 31419791

Group type: EXPERIMENTAL
Intervention: 8 Gy in 3 fractions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 9 Gy in 3 fractions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10 Gy in 3 fractions
Number of subjects: 60

Group type: COMPARATOR
Intervention: 24 Gy in 3 fractions
Number of subjects: 60

Group type: COMPARATOR
Intervention: 30 Gy in 3 fractions
Number of subjects: 60
Study: 29122789

Group type: EXPERIMENTAL
Intervention: DEMO score obtained
Number of subjects: 383
Study: 25215434

Group type: EXPERIMENTAL
Intervention: High-dose dialysis
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard-dose dialysis
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: High-flux dialyzer
Number of subjects: 140

Group type: COMPARATOR
Intervention: Low-flux dialyzer
Number of subjects: 140
Study: 23750466

Group type: EXPERIMENTAL
Intervention: New Beginnings Program (NBP)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Literature Control (LC)
Number of subjects: 240
Study: 20855549

Group type: EXPERIMENTAL
Intervention: A1C ≥6.5%
Number of subjects: 12485

Group type: EXPERIMENTAL
Intervention: A1C 5.7-<6.5%
Number of subjects: 12485
Study: 18645246

Group type: EXPERIMENTAL
Intervention: Dealcoholized red wine (DRW)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 27
Study: 16946657

Group type: EXPERIMENTAL
Intervention: Bupivacaine and methylprednisolone (30 mL 0.25% bupivacaine and 40 mg methylprednisolone) before wound closure
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Bupivacaine alone (30 mL 0.25% bupivacaine) before closure
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Bupivacaine and methylprednisolone (30 mL 0.25% bupivacaine and 40 mg methylprednisolone) before incision
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Bupivacaine alone (30 mL 0.25% bupivacaine) before incision
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (30 mL 0.9% NaCl before wound closure)
Number of subjects: 75
Study: 12880362

Group type: EXPERIMENTAL
Intervention: 1450-nm laser treatment with dynamic cooling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control side (no treatment)
Number of subjects: 0
Study: 10875487

Group type: EXPERIMENTAL
Intervention: Clarithromycin 200 mg twice daily for 8 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 9180600

Group type: EXPERIMENTAL
Intervention: 40 mg/kg in one oral dose
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: two oral doses of 30 mg/kg at a 6-hr interval
Number of subjects: 130
Study: 8257124

Group type: EXPERIMENTAL
Intervention: Ultramicrosize griseofulvin (UMSG) at 660 mg/day
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Ultramicrosize griseofulvin (UMSG) at 990 mg/day
Number of subjects: 109

Group type: COMPARATOR
Intervention: Itraconazole at 100 mg/day
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Side effects (nausea, diarrhea, headache)
Number of subjects: 109
Study: 2984100

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg sublingually
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 31232495

Group type: EXPERIMENTAL
Intervention: CAA-related ICH
Number of subjects: 5900

Group type: EXPERIMENTAL
Intervention: CAA-ri
Number of subjects: 5900
Study: 29794285

Group type: EXPERIMENTAL
Intervention: Mycophenolate treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (usual treatment)
Number of subjects: 12
Study: 26627899

Group type: EXPERIMENTAL
Intervention: Fortifying milk on measured composition according to birth weight criteria and postmenstrual age (PMA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine practice of fortifying on assumed milk composition
Number of subjects: 0
Study: 23755093

Group type: EXPERIMENTAL
Intervention: Oxygen supplementation at 2 or 3 L/min for 72 hours
Number of subjects: 289

Group type: COMPARATOR
Intervention: Control treatment (room air)
Number of subjects: 289
Study: 22198653

Group type: EXPERIMENTAL
Intervention: Reamed intramedullary nail (n = 56)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Standard large fragment medial plate (n = 48)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Both interventions (n = 104)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Unemployed patients (n = 104)
Number of subjects: 104
Study: 20372111

Group type: EXPERIMENTAL
Intervention: Pediatric Crohn's Disease Activity Index (PCDAI)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: PCDAI for mild disease
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: PCDAI for moderate disease
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: PCDAI for severe disease
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: PCDAI response measurement
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Test-retest reliability of PCDAI
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Responsiveness of PCDAI
Number of subjects: 437
Study: 18528903

Group type: EXPERIMENTAL
Intervention: Heat and moisture exchanger (HME)
Number of subjects: 10
Study: 15882228

Group type: EXPERIMENTAL
Intervention: 10 ml erythrosine mouthwash for 15 s rinsing period
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 ml erythrosine mouthwash for 30 s rinsing period
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 ml erythrosine mouthwash for 60 s rinsing period
Number of subjects: 30

Group type: COMPARATOR
Intervention: 10 ml erythrosine mouthwash for 90 s rinsing period
Number of subjects: 30
Study: 12947730

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 58

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 58
Study: 10475181

Group type: EXPERIMENTAL
Intervention: Early invasive treatment strategy
Number of subjects: 2457

Group type: COMPARATOR
Intervention: Non-invasive treatment strategy
Number of subjects: 2457
Study: 8732321

Group type: EXPERIMENTAL
Intervention: Results of a self‐administered computerized assessment (PROQSY) of common mental disorders provided to the GP
Number of subjects: 681

Group type: COMPARATOR
Intervention: Results of the 12 item General Health Questionnaire (GHQ) provided to the GP
Number of subjects: 681

Group type: COMPARATOR
Intervention: No additional information given to the GP
Number of subjects: 681
Study: 1890863

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation following high dose chemotherapy and radiation therapy (RT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RT followed by adjuvant chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 0
Study: 6579843

Group type: EXPERIMENTAL
Intervention: Budesonide (intranasal corticosteroid)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 30556961

Group type: EXPERIMENTAL
Intervention: Topical 0.1% triamcinolone (TA) preparation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Topical 0.2% hyaluronic acid (HA) preparation
Number of subjects: 40
Study: 27825036

Group type: EXPERIMENTAL
Intervention: MAPS+ (Motivation And Problem Solving Plus)
Number of subjects: 202

Group type: COMPARATOR
Intervention: S-MAPS (Standard MAPS treatment)
Number of subjects: 202
Study: 25369831

Group type: EXPERIMENTAL
Intervention: Rimostil (50 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23722649

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 60
Study: 20371736

Group type: EXPERIMENTAL
Intervention: Linezolid with rifampin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Linezolid alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Linezolid and rifampin (combination)
Number of subjects: 16
Study: 19738292

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training without electrical stimulation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training with electrical stimulation
Number of subjects: 24
Study: 16937509

Group type: EXPERIMENTAL
Intervention: Combined indwelling catheter celiac drainage and intra-abdominal pressure monitoring, routine conservative measures (group 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine non-operative conservative treatments (group 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined indwelling catheter celiac drainage and intra-abdominal pressure monitoring (group 1)
Number of subjects: 0
Study: 14618331

Group type: EXPERIMENTAL
Intervention: Isokinetic weight training three times per week for 12 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Strength training for 2, 4, or 6 weeks prior to cycle ergometry
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Concurrent weight training during FES cycle ergometry three times per week
Number of subjects: 45
Study: 11737179

Group type: EXPERIMENTAL
Intervention: Sevoflurane-nitrous oxide anaesthesia
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 infusion
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no hypotensive agent)
Number of subjects: 45
Study: 9224079

Group type: EXPERIMENTAL
Intervention: Intervention group consuming eight servings of fruit and vegetables a day
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 87
Study: 7957150

Group type: EXPERIMENTAL
Intervention: Endurance exercise at 85% of IAT (E85)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Endurance exercise at 95% of IAT (E95)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Endurance exercise at 100% of IAT (E100)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Endurance exercise at 105% of IAT (E105)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Endurance exercises at or below IAT (E85-E100)
Number of subjects: 14
Study: 3591681

Group type: EXPERIMENTAL
Intervention: Pindolol (mean dose 17 +/- 8 mg/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Propranolol (130 +/- 40 mg/day)
Number of subjects: 11
Study: 30952118

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) in the LQ study
Number of subjects: 69

Group type: COMPARATOR
Intervention: Deep brain stimulation (DBS) in the VA/NINDS trial
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) in the LQ study among levodopa full responders
Number of subjects: 69

Group type: COMPARATOR
Intervention: Deep brain stimulation (DBS) in the VA/NINDS trial among levodopa full responders
Number of subjects: 69
Study: 28958804

Group type: EXPERIMENTAL
Intervention: Low glycemic index (LGI) diet
Number of subjects: 201

Group type: COMPARATOR
Intervention: High-cereal fibre diet
Number of subjects: 201
Study: 27442394

Group type: EXPERIMENTAL
Intervention: GA + TAP-D block with 25 ml of 0.5% ropivacaine + 4 mg Dexamethasone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: GA + TAP block with 25 ml of 0.5% ropivacaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: GA
Number of subjects: 90
Study: 22987794

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Successful Aging (SA) education program
Number of subjects: 424
Study: 21998477

Group type: EXPERIMENTAL
Intervention: Live attenuated vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inactivated vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18438931

Group type: EXPERIMENTAL
Intervention: Medial insole (insoles with 8‐mm medial elevation at the rearfoot, n = 16)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neutral insole (similar insole without elevation, n = 14)
Number of subjects: 30
Study: 17069958

Group type: EXPERIMENTAL
Intervention: Compression: ventilation ratio 15:2
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Compression: ventilation ratio 30:2
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Continuous chest compressions without ventilations
Number of subjects: 68
Study: 15452808

Group type: EXPERIMENTAL
Intervention: Demineralized bone powder (DBP)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Guided-tissue regeneration therapy (GTR therapy)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 24
Study: 11605925

Group type: EXPERIMENTAL
Intervention: QoR-40 (quality of recovery score) on days 1-3 and 1 month after surgery
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SF-36 (short-form health survey) at 1 and 3 months after surgery
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: QoR-40 on day 3
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Poor-quality recovery in hospital
Number of subjects: 120
Study: 9699821

Group type: EXPERIMENTAL
Intervention: Cemented TKR
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Uncemented TKR
Number of subjects: 110

Group type: COMPARATOR
Intervention: Cemented THR
Number of subjects: 110
Study: 8007587

Group type: EXPERIMENTAL
Intervention: Continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 4136
Study: 12283017

Group type: EXPERIMENTAL
Intervention: SED-S (sucrose-free semi-elemental diet)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: SED+S (sucrose-containing semi-elemental diet)
Number of subjects: 74
Study: 31635898

Group type: EXPERIMENTAL
Intervention: Clarithromycin (CAM) and glucocorticoid (DEX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) and Clarithromycin (CAM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-17A and IL-6
Number of subjects: 0
Study: 28128977

Group type: EXPERIMENTAL
Intervention: Tailored Intervention (TI)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 118
Study: 27183373

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 110

Group type: COMPARATOR
Intervention: Palpation
Number of subjects: 110